nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—urine—hypothyroidism	0.0641	0.19	CbGeAlD
Raltegravir—Basedow's disease—Levothyroxine—hypothyroidism	0.0464	0.08	CcSEcCtD
Raltegravir—Basedow's disease—Dextrothyroxine—hypothyroidism	0.0464	0.08	CcSEcCtD
Raltegravir—CCR1—heart—hypothyroidism	0.04	0.119	CbGeAlD
Raltegravir—CCR1—cardiovascular system—hypothyroidism	0.0377	0.112	CbGeAlD
Raltegravir—Basedow's disease—Liotrix—hypothyroidism	0.0341	0.0588	CcSEcCtD
Raltegravir—CCR1—pituitary gland—hypothyroidism	0.0334	0.0992	CbGeAlD
Raltegravir—CCR1—adrenal gland—hypothyroidism	0.0298	0.0886	CbGeAlD
Raltegravir—CCR1—blood—hypothyroidism	0.0298	0.0886	CbGeAlD
Raltegravir—CCR1—thyroid gland—hypothyroidism	0.0288	0.0855	CbGeAlD
Raltegravir—CCR1—female gonad—hypothyroidism	0.0278	0.0826	CbGeAlD
Raltegravir—CCR1—liver—hypothyroidism	0.0233	0.0693	CbGeAlD
Raltegravir—Renal tubular necrosis—Liotrix—hypothyroidism	0.0209	0.036	CcSEcCtD
Raltegravir—Epigastric discomfort—Liotrix—hypothyroidism	0.0142	0.0244	CcSEcCtD
Raltegravir—UGT1A1—blood—hypothyroidism	0.0123	0.0364	CbGeAlD
Raltegravir—CCR1—Peptide GPCRs—TSHR—hypothyroidism	0.0123	0.148	CbGpPWpGaD
Raltegravir—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0114	0.0196	CcSEcCtD
Raltegravir—Myocardial infarction—Liothyronine—hypothyroidism	0.0113	0.0195	CcSEcCtD
Raltegravir—UGT1A1—liver—hypothyroidism	0.00959	0.0285	CbGeAlD
Raltegravir—Increased appetite—Levothyroxine—hypothyroidism	0.00783	0.0135	CcSEcCtD
Raltegravir—Increased appetite—Dextrothyroxine—hypothyroidism	0.00783	0.0135	CcSEcCtD
Raltegravir—Hypertension—Liothyronine—hypothyroidism	0.00779	0.0134	CcSEcCtD
Raltegravir—Affect lability—Levothyroxine—hypothyroidism	0.00724	0.0125	CcSEcCtD
Raltegravir—Affect lability—Dextrothyroxine—hypothyroidism	0.00724	0.0125	CcSEcCtD
Raltegravir—Blood urea increased—Liotrix—hypothyroidism	0.00704	0.0121	CcSEcCtD
Raltegravir—Mood swings—Levothyroxine—hypothyroidism	0.00697	0.012	CcSEcCtD
Raltegravir—Mood swings—Dextrothyroxine—hypothyroidism	0.00697	0.012	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00647	0.078	CbGpPWpGaD
Raltegravir—Body temperature increased—Liothyronine—hypothyroidism	0.00582	0.01	CcSEcCtD
Raltegravir—Increased appetite—Liotrix—hypothyroidism	0.00576	0.00992	CcSEcCtD
Raltegravir—Weight decreased—Levothyroxine—hypothyroidism	0.00575	0.00991	CcSEcCtD
Raltegravir—Weight decreased—Dextrothyroxine—hypothyroidism	0.00575	0.00991	CcSEcCtD
Raltegravir—Renal impairment—Liotrix—hypothyroidism	0.00568	0.00979	CcSEcCtD
Raltegravir—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00559	0.00963	CcSEcCtD
Raltegravir—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00559	0.00963	CcSEcCtD
Raltegravir—Myocardial infarction—Levothyroxine—hypothyroidism	0.00556	0.00957	CcSEcCtD
Raltegravir—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00556	0.00957	CcSEcCtD
Raltegravir—Affect lability—Liotrix—hypothyroidism	0.00533	0.00918	CcSEcCtD
Raltegravir—Mood swings—Liotrix—hypothyroidism	0.00513	0.00883	CcSEcCtD
Raltegravir—Blood creatinine increased—Liotrix—hypothyroidism	0.00507	0.00873	CcSEcCtD
Raltegravir—Abdominal distension—Liotrix—hypothyroidism	0.00471	0.00811	CcSEcCtD
Raltegravir—Bronchitis—Liotrix—hypothyroidism	0.0045	0.00775	CcSEcCtD
Raltegravir—Alopecia—Levothyroxine—hypothyroidism	0.0045	0.00775	CcSEcCtD
Raltegravir—Alopecia—Dextrothyroxine—hypothyroidism	0.0045	0.00775	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00434	0.0523	CbGpPWpGaD
Raltegravir—Nervousness—Dextrothyroxine—hypothyroidism	0.0043	0.00741	CcSEcCtD
Raltegravir—Nervousness—Levothyroxine—hypothyroidism	0.0043	0.00741	CcSEcCtD
Raltegravir—Weight decreased—Liotrix—hypothyroidism	0.00423	0.00729	CcSEcCtD
Raltegravir—Tremor—Dextrothyroxine—hypothyroidism	0.00415	0.00715	CcSEcCtD
Raltegravir—Tremor—Levothyroxine—hypothyroidism	0.00415	0.00715	CcSEcCtD
Raltegravir—Acute coronary syndrome—Liotrix—hypothyroidism	0.00411	0.00708	CcSEcCtD
Raltegravir—Renal failure—Liotrix—hypothyroidism	0.0041	0.00706	CcSEcCtD
Raltegravir—Myocardial infarction—Liotrix—hypothyroidism	0.00409	0.00704	CcSEcCtD
Raltegravir—Agitation—Levothyroxine—hypothyroidism	0.00407	0.00701	CcSEcCtD
Raltegravir—Agitation—Dextrothyroxine—hypothyroidism	0.00407	0.00701	CcSEcCtD
Raltegravir—Palpitations—Dextrothyroxine—hypothyroidism	0.00391	0.00674	CcSEcCtD
Raltegravir—Palpitations—Levothyroxine—hypothyroidism	0.00391	0.00674	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00387	0.0466	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00387	0.0466	CbGpPWpGaD
Raltegravir—Arthralgia—Levothyroxine—hypothyroidism	0.00377	0.0065	CcSEcCtD
Raltegravir—Arthralgia—Dextrothyroxine—hypothyroidism	0.00377	0.0065	CcSEcCtD
Raltegravir—Anxiety—Levothyroxine—hypothyroidism	0.00376	0.00647	CcSEcCtD
Raltegravir—Anxiety—Dextrothyroxine—hypothyroidism	0.00376	0.00647	CcSEcCtD
Raltegravir—Hypoaesthesia—Liotrix—hypothyroidism	0.00372	0.00642	CcSEcCtD
Raltegravir—Confusional state—Levothyroxine—hypothyroidism	0.00365	0.00628	CcSEcCtD
Raltegravir—Confusional state—Dextrothyroxine—hypothyroidism	0.00365	0.00628	CcSEcCtD
Raltegravir—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00349	0.00602	CcSEcCtD
Raltegravir—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00349	0.00602	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—AVP—hypothyroidism	0.0034	0.041	CbGpPWpGaD
Raltegravir—Alopecia—Liotrix—hypothyroidism	0.00331	0.0057	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—TRH—hypothyroidism	0.0033	0.0398	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00329	0.00567	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00329	0.00567	CcSEcCtD
Raltegravir—Insomnia—Dextrothyroxine—hypothyroidism	0.00327	0.00563	CcSEcCtD
Raltegravir—Insomnia—Levothyroxine—hypothyroidism	0.00327	0.00563	CcSEcCtD
Raltegravir—Flatulence—Liotrix—hypothyroidism	0.00321	0.00553	CcSEcCtD
Raltegravir—Dysgeusia—Liotrix—hypothyroidism	0.00319	0.0055	CcSEcCtD
Raltegravir—Nervousness—Liotrix—hypothyroidism	0.00316	0.00545	CcSEcCtD
Raltegravir—Fatigue—Levothyroxine—hypothyroidism	0.00312	0.00537	CcSEcCtD
Raltegravir—Fatigue—Dextrothyroxine—hypothyroidism	0.00312	0.00537	CcSEcCtD
Raltegravir—Tremor—Liotrix—hypothyroidism	0.00305	0.00526	CcSEcCtD
Raltegravir—Agitation—Liotrix—hypothyroidism	0.00299	0.00516	CcSEcCtD
Raltegravir—Feeling abnormal—Levothyroxine—hypothyroidism	0.00298	0.00513	CcSEcCtD
Raltegravir—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00298	0.00513	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00296	0.00509	CcSEcCtD
Raltegravir—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00296	0.00509	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—TSHB—hypothyroidism	0.00294	0.0355	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—TSHR—hypothyroidism	0.00294	0.0355	CbGpPWpGaD
Raltegravir—Palpitations—Liotrix—hypothyroidism	0.00288	0.00496	CcSEcCtD
Raltegravir—Urticaria—Levothyroxine—hypothyroidism	0.00287	0.00495	CcSEcCtD
Raltegravir—Urticaria—Dextrothyroxine—hypothyroidism	0.00287	0.00495	CcSEcCtD
Raltegravir—Abdominal pain—Levothyroxine—hypothyroidism	0.00286	0.00492	CcSEcCtD
Raltegravir—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00286	0.00492	CcSEcCtD
Raltegravir—Body temperature increased—Levothyroxine—hypothyroidism	0.00286	0.00492	CcSEcCtD
Raltegravir—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00286	0.00492	CcSEcCtD
Raltegravir—Hypertension—Liotrix—hypothyroidism	0.00281	0.00485	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—SLC5A7—hypothyroidism	0.00278	0.0335	CbGpPWpGaD
Raltegravir—Chest pain—Liotrix—hypothyroidism	0.00277	0.00478	CcSEcCtD
Raltegravir—Arthralgia—Liotrix—hypothyroidism	0.00277	0.00478	CcSEcCtD
Raltegravir—Anxiety—Liotrix—hypothyroidism	0.00276	0.00476	CcSEcCtD
Raltegravir—Confusional state—Liotrix—hypothyroidism	0.00268	0.00462	CcSEcCtD
Raltegravir—Infection—Liotrix—hypothyroidism	0.00264	0.00455	CcSEcCtD
Raltegravir—Asthenia—Dextrothyroxine—hypothyroidism	0.00259	0.00447	CcSEcCtD
Raltegravir—Asthenia—Levothyroxine—hypothyroidism	0.00259	0.00447	CcSEcCtD
Raltegravir—Hyperhidrosis—Liotrix—hypothyroidism	0.00257	0.00443	CcSEcCtD
Raltegravir—Pruritus—Levothyroxine—hypothyroidism	0.00256	0.00441	CcSEcCtD
Raltegravir—Pruritus—Dextrothyroxine—hypothyroidism	0.00256	0.00441	CcSEcCtD
Raltegravir—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00247	0.00426	CcSEcCtD
Raltegravir—Diarrhoea—Levothyroxine—hypothyroidism	0.00247	0.00426	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00242	0.00417	CcSEcCtD
Raltegravir—Insomnia—Liotrix—hypothyroidism	0.00241	0.00414	CcSEcCtD
Raltegravir—Paraesthesia—Liotrix—hypothyroidism	0.00239	0.00411	CcSEcCtD
Raltegravir—Decreased appetite—Liotrix—hypothyroidism	0.00231	0.00398	CcSEcCtD
Raltegravir—Vomiting—Dextrothyroxine—hypothyroidism	0.0023	0.00396	CcSEcCtD
Raltegravir—Vomiting—Levothyroxine—hypothyroidism	0.0023	0.00396	CcSEcCtD
Raltegravir—Fatigue—Liotrix—hypothyroidism	0.00229	0.00395	CcSEcCtD
Raltegravir—Rash—Dextrothyroxine—hypothyroidism	0.00228	0.00393	CcSEcCtD
Raltegravir—Rash—Levothyroxine—hypothyroidism	0.00228	0.00393	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00228	0.0275	CbGpPWpGaD
Raltegravir—Dermatitis—Dextrothyroxine—hypothyroidism	0.00228	0.00392	CcSEcCtD
Raltegravir—Dermatitis—Levothyroxine—hypothyroidism	0.00228	0.00392	CcSEcCtD
Raltegravir—Constipation—Liotrix—hypothyroidism	0.00227	0.00392	CcSEcCtD
Raltegravir—Headache—Dextrothyroxine—hypothyroidism	0.00226	0.0039	CcSEcCtD
Raltegravir—Headache—Levothyroxine—hypothyroidism	0.00226	0.0039	CcSEcCtD
Raltegravir—CCR1—Peptide ligand-binding receptors—POMC—hypothyroidism	0.00226	0.0272	CbGpPWpGaD
Raltegravir—Feeling abnormal—Liotrix—hypothyroidism	0.00219	0.00378	CcSEcCtD
Raltegravir—Gastrointestinal pain—Liotrix—hypothyroidism	0.00217	0.00375	CcSEcCtD
Raltegravir—Nausea—Dextrothyroxine—hypothyroidism	0.00215	0.0037	CcSEcCtD
Raltegravir—Nausea—Levothyroxine—hypothyroidism	0.00215	0.0037	CcSEcCtD
Raltegravir—Urticaria—Liotrix—hypothyroidism	0.00211	0.00364	CcSEcCtD
Raltegravir—Abdominal pain—Liotrix—hypothyroidism	0.0021	0.00362	CcSEcCtD
Raltegravir—Body temperature increased—Liotrix—hypothyroidism	0.0021	0.00362	CcSEcCtD
Raltegravir—Hypersensitivity—Liotrix—hypothyroidism	0.00196	0.00338	CcSEcCtD
Raltegravir—Asthenia—Liotrix—hypothyroidism	0.00191	0.00329	CcSEcCtD
Raltegravir—CCR1—G alpha (i) signalling events—POMC—hypothyroidism	0.0019	0.023	CbGpPWpGaD
Raltegravir—Pruritus—Liotrix—hypothyroidism	0.00188	0.00324	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—TRH—hypothyroidism	0.00187	0.0225	CbGpPWpGaD
Raltegravir—Diarrhoea—Liotrix—hypothyroidism	0.00182	0.00313	CcSEcCtD
Raltegravir—Dizziness—Liotrix—hypothyroidism	0.00176	0.00303	CcSEcCtD
Raltegravir—CCR1—GPCR ligand binding—AVP—hypothyroidism	0.00174	0.0209	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TRH—hypothyroidism	0.0017	0.0204	CbGpPWpGaD
Raltegravir—Vomiting—Liotrix—hypothyroidism	0.00169	0.00291	CcSEcCtD
Raltegravir—Rash—Liotrix—hypothyroidism	0.00168	0.00289	CcSEcCtD
Raltegravir—Dermatitis—Liotrix—hypothyroidism	0.00168	0.00289	CcSEcCtD
Raltegravir—Headache—Liotrix—hypothyroidism	0.00167	0.00287	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—TSHR—hypothyroidism	0.00166	0.0201	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TSHB—hypothyroidism	0.00166	0.0201	CbGpPWpGaD
Raltegravir—Nausea—Liotrix—hypothyroidism	0.00158	0.00272	CcSEcCtD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00151	0.0183	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TSHB—hypothyroidism	0.00151	0.0182	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TSHR—hypothyroidism	0.00151	0.0182	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CLTC—hypothyroidism	0.00116	0.014	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—POMC—hypothyroidism	0.00115	0.0139	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC5A5—hypothyroidism	0.00111	0.0134	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—VAV3—hypothyroidism	0.00102	0.0123	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TRH—hypothyroidism	0.001	0.0121	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AVP—hypothyroidism	0.000981	0.0118	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—VAV3—hypothyroidism	0.000924	0.0111	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TSHB—hypothyroidism	0.000893	0.0108	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TSHR—hypothyroidism	0.000893	0.0108	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AVP—hypothyroidism	0.000891	0.0107	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SH2B3—hypothyroidism	0.000796	0.00959	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—POMC—hypothyroidism	0.000652	0.00786	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—IYD—hypothyroidism	0.000601	0.00725	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—POMC—hypothyroidism	0.000592	0.00714	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRL—hypothyroidism	0.00059	0.00712	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VAV3—hypothyroidism	0.000546	0.00658	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AVP—hypothyroidism	0.000526	0.00634	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ATP5O—hypothyroidism	0.000511	0.00616	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—POMC—hypothyroidism	0.00051	0.00614	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TPO—hypothyroidism	0.000481	0.0058	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—POMC—hypothyroidism	0.00035	0.00421	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1—hypothyroidism	0.000336	0.00405	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—TSHB—hypothyroidism	0.000223	0.00268	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3C2A—hypothyroidism	0.000198	0.00239	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC5A5—hypothyroidism	0.000167	0.00201	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—hypothyroidism	8.72e-05	0.00105	CbGpPWpGaD
